BMO lists 3 top biotech ideas for H2 Jul 1, 2025 06:00AM
BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN) Jun 2, 2025 05:08AM
BMO Capital Reiterates Outperform on Legend Biotech Corp. (LEGN), Sees 'Upside in 2025' Mar 12, 2025 10:18AM
BMO Capital Highlights Favorite Names for 2025 in Biotech Dec 20, 2024 12:46PM
BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN) Oct 16, 2024 07:45AM


Oct 9, 2024 07:28AM BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
Sep 30, 2024 08:27AM BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
Aug 12, 2024 12:43PM BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
Jul 2, 2024 03:04PM BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
Apr 17, 2024 12:04PM BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
Mar 14, 2024 07:43AM BMO Capital Reiterates Outperform Rating on Legend Biotech Corp. (LEGN)
Jul 27, 2022 05:55AM Legend Biotech (LEGN) Prices 8.14M ADS Offering at $43/sh
Jul 26, 2022 08:00PM Legend Biotech Corporation Announces Pricing of Public Offering
Jul 25, 2022 04:02PM Legend Biotech (LEGN) Announces Proposed $250M Share Offering
Jul 25, 2022 04:01PM Legend Biotech Corporation Announces Proposed Public Offering
Jul 8, 2022 01:05PM Legand Biotech (LEGN) Thesis Intact Despite LB1901 Trial Termination - BMO
Jun 16, 2022 04:15PM UPDATE: BMO Capital Starts Legand Biotech Corp. (LEGN) at Outperform, Top Pick